CircUSPL1 deficiency repressed BC cell malignant phenotypes through reducing MTA1 via targeting miR-1296-5p, which might provide a theoretical basis for BC treatment.
Silencing of circUSPL1 represses breast cancer progression by targeting miR-1296-5p/MTA1 axis.